Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "virus"

478 News Found

Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest
Biotech | August 13, 2021

Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest

Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose


Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
Drug Approval | August 12, 2021

Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness

A treatment to prevent extreme symptoms and cut hospitalisation


QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater
Drug Approval | August 11, 2021

QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases


Moderna to set up mRNA manufacturing in Canada
Biotech | August 11, 2021

Moderna to set up mRNA manufacturing in Canada

The collaboration will support Canada with direct access to rapid pandemic response capabilities


GSK files application for MMR vaccine in the US
News | August 11, 2021

GSK files application for MMR vaccine in the US

If approved it will bring a second source of MMR vaccine to the US market


INNOVIO QoQ revenues down for the period ended June 30, 2021
Biotech | August 10, 2021

INNOVIO QoQ revenues down for the period ended June 30, 2021

Company working on COVID vaccine INO 4800


QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour
Digitisation | August 10, 2021

QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour

QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes


NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Drug Approval | August 10, 2021

NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19

Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant


AIkido updates on use of machine learning in drug development orogram
Digitisation | August 09, 2021

AIkido updates on use of machine learning in drug development orogram

The goal for the project is the identification and optimization of anti-viral compounds.